BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Day CP. Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int. 2006;26:1021-1028. [PMID: 17032401 DOI: 10.1111/j.1478-3231.2006.01323.x] [Cited by in Crossref: 110] [Cited by in F6Publishing: 113] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Nezi V, Deutsch M, Gazouli M, Alexopoulou A, Paparrigopoulos T, Liappas IA, Dourakis SP. Polymorphisms of the CD14 genes are associated with susceptibility to alcoholic liver disease in Greek patients. Alcohol Clin Exp Res. 2013;37:244-251. [PMID: 23009036 DOI: 10.1111/j.1530-0277.2012.01925.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
2 Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, Mascianà R, Forgione A, Gabrieli ML, Perotti G, Vecchio FM, Rapaccini G, Gasbarrini G, Day CP, Grieco A. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 2009;49:1877-87. [DOI: 10.1002/hep.22848] [Cited by in Crossref: 785] [Cited by in F6Publishing: 768] [Article Influence: 60.4] [Reference Citation Analysis]
3 Udoh US, Valcin JA, Gamble KL, Bailey SM. The Molecular Circadian Clock and Alcohol-Induced Liver Injury. Biomolecules 2015;5:2504-37. [PMID: 26473939 DOI: 10.3390/biom5042504] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
4 Lee YH, Kim SH, Lee S, Kim KM, Jung JC, Son TG, Ki SH, Seo WD, Kwak JH, Hong JT, Jung YS. Antioxidant Effect of Barley Sprout Extract via Enhancement of Nuclear Factor-Erythroid 2 Related Factor 2 Activity and Glutathione Synthesis. Nutrients 2017;9:E1252. [PMID: 29144408 DOI: 10.3390/nu9111252] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
5 Alisi A, Manco M, Devito R, Piemonte F, Nobili V. Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2010;50:645-649. [PMID: 20400911 DOI: 10.1097/mpg.0b013e3181c7bdf1] [Cited by in Crossref: 96] [Cited by in F6Publishing: 58] [Article Influence: 8.0] [Reference Citation Analysis]
6 Kendrick SF, Day CP. A coffee with your brandy, Sir? Journal of Hepatology 2007;46:980-2. [DOI: 10.1016/j.jhep.2007.02.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
7 Kamagate A, Qu S, Perdomo G, Su D, Kim DH, Slusher S, Meseck M, Dong HH. FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. J Clin Invest. 2008;118:2347-2364. [PMID: 18497885 DOI: 10.1172/jci32914.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Novo E, Parola M. Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair 2008;1:5. [PMID: 19014652 DOI: 10.1186/1755-1536-1-5] [Cited by in Crossref: 246] [Cited by in F6Publishing: 210] [Article Influence: 17.6] [Reference Citation Analysis]
9 Li YG, Ji DF, Zhong S, Shi LG, Hu GY, Chen S. Saponins from Panax japonicus protect against alcohol-induced hepatic injury in mice by up-regulating the expression of GPX3, SOD1 and SOD3. Alcohol Alcohol. 2010;45:320-331. [PMID: 20554696 DOI: 10.1093/alcalc/agq034] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
10 Vizzutti; F, Arena; U, Nobili; V, Tarquini; R, Trappoliere; M, Laffi; G, Marra; F, Pinzani M. Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD). Annals of Hepatology 2009;8:89-94. [DOI: 10.1016/s1665-2681(19)31784-3] [Cited by in Crossref: 30] [Article Influence: 2.3] [Reference Citation Analysis]
11 Kaiser JP, Beier JI, Zhang J, David Hoetker J, von Montfort C, Guo L, Zheng Y, Monia BP, Bhatnagar A, Arteel GE. PKCepsilon plays a causal role in acute ethanol-induced steatosis. Arch Biochem Biophys. 2009;482:104-111. [PMID: 19022218 DOI: 10.1016/j.abb.2008.11.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
12 Tomita K, Teratani T, Suzuki T, Oshikawa T, Yokoyama H, Shimamura K, Nishiyama K, Mataki N, Irie R, Minamino T. p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice. J Hepatol. 2012;57:837-843. [PMID: 22641095 DOI: 10.1016/j.jhep.2012.05.013] [Cited by in Crossref: 69] [Cited by in F6Publishing: 72] [Article Influence: 6.9] [Reference Citation Analysis]
13 Han CC, Wang JW, Pan ZX, Tang H, Xiang SX, Wang J, Li L, Xu F, Wei SH. Effect of liver X receptor activation on the very low density lipoprotein secretion and messenger ribonucleic acid level of related genes in goose primary hepatocytes. Poult Sci 2011;90:402-9. [PMID: 21248338 DOI: 10.3382/ps.2010-00995] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
14 Bataller R, Rombouts K, Altamirano J, Marra F. Fibrosis in alcoholic and nonalcoholic steatohepatitis. Best Practice & Research Clinical Gastroenterology 2011;25:231-44. [DOI: 10.1016/j.bpg.2011.02.010] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
15 Marciano F, Savoia M, Vajro P. Celiac disease-related hepatic injury: Insights into associated conditions and underlying pathomechanisms. Dig Liver Dis. 2016;48:112-119. [PMID: 26711682 DOI: 10.1016/j.dld.2015.11.013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
16 Mantena SK, King AL, Andringa KK, Eccleston HB, Bailey SM. Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic Biol Med. 2008;44:1259-1272. [PMID: 18242193 DOI: 10.1016/j.freeradbiomed.2007.12.029] [Cited by in Crossref: 291] [Cited by in F6Publishing: 274] [Article Influence: 20.8] [Reference Citation Analysis]
17 Schindhelm RK, Diamant M, Heine RJ. Nonalcoholic fatty liver disease and cardiovascular disease risk. Curr Diab Rep 2007;7:181-7. [PMID: 17547835 DOI: 10.1007/s11892-007-0030-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
18 Hori M, Oniki K, Nakagawa T, Takata K, Mihara S, Marubayashi T, Nakagawa K. Association between combinations of glutathione-S-transferase M1, T1 and P1 genotypes and non-alcoholic fatty liver disease. Liver Int. 2009;29:164-168. [PMID: 18492019 DOI: 10.1111/j.1478-3231.2008.01794.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
19 Machado M, Cortez-pinto H. Are genes really important in alcoholic liver disease?: . European Journal of Gastroenterology & Hepatology 2008;20:1244-8. [DOI: 10.1097/meg.0b013e328304b6dd] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
20 Wan X, Xu C, Lin Y, Lu C, Li D, Sang J, He H, Liu X, Li Y, Yu C. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. J Hepatol. 2016;64:925-932. [PMID: 26639394 DOI: 10.1016/j.jhep.2015.11.022] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 10.6] [Reference Citation Analysis]
21 Purohit V, Gao B, Song BJ. Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res 2009;33:191-205. [PMID: 19032584 DOI: 10.1111/j.1530-0277.2008.00827.x] [Cited by in Crossref: 191] [Cited by in F6Publishing: 187] [Article Influence: 13.6] [Reference Citation Analysis]
22 An HJ, Lee YJ, Choe CP, Cho HK, Song DH. Long noncoding RNAs associated with nonalcoholic fatty liver disease in a high cholesterol diet adult zebrafish model. Sci Rep 2021;11:23005. [PMID: 34837012 DOI: 10.1038/s41598-021-02455-0] [Reference Citation Analysis]
23 Fengler VH, Macheiner T, Kessler SM, Czepukojc B, Gemperlein K, Müller R, Kiemer AK, Magnes C, Haybaeck J, Lackner C, Sargsyan K. Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver Disease. PLoS One 2016;11:e0155163. [PMID: 27167736 DOI: 10.1371/journal.pone.0155163] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
24 Nobili V, Alisi A, Raponi M. Pediatric non-alcoholic fatty liver disease: Preventive and therapeutic value of lifestyle intervention. World J Gastroenterol 2009; 15(48): 6017-6022 [PMID: 20027672 DOI: 10.3748/wjg.15.6017] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
25 Hajighasem A, Farzanegi P, Mazaheri Z. Effects of combined therapy with resveratrol, continuous and interval exercises on apoptosis, oxidative stress, and inflammatory biomarkers in the liver of old rats with non-alcoholic fatty liver disease. Arch Physiol Biochem. 2018;1-8. [PMID: 29463133 DOI: 10.1080/13813455.2018.1441872] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
26 Rasool A, Zulfajri M, Gulzar A, Hanafiah MM, Unnisa SA, Mahboob M. In vitro effects of cobalt nanoparticles on aspartate aminotransferase and alanine aminotransferase activities of wistar rats. Biotechnol Rep (Amst) 2020;26:e00453. [PMID: 32368512 DOI: 10.1016/j.btre.2020.e00453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Gerhard GS, Benotti P, Wood GC, Chu X, Argyropoulos G, Petrick A, Strodel WE, Gabrielsen JD, Ibele A, Still CD, Kingsley C, DiStefano J. Identification of novel clinical factors associated with hepatic fat accumulation in extreme obesity. J Obes 2014;2014:368210. [PMID: 25610640 DOI: 10.1155/2014/368210] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
28 Loomba R, Hwang SJ, O'Donnell CJ, Ellison RC, Vasan RS, D'Agostino RB Sr, Liang TJ, Fox CS. Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the Framingham heart study. Gastroenterology 2008;134:953-9. [PMID: 18395076 DOI: 10.1053/j.gastro.2008.01.037] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.0] [Reference Citation Analysis]
29 Gäbele E, Dostert K, Dorn C, Patsenker E, Stickel F, Hellerbrand C. A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis. Alcohol Clin Exp Res. 2011;35:1361-1367. [PMID: 21463337 DOI: 10.1111/j.1530-0277.2011.01472.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 4.9] [Reference Citation Analysis]
30 Alisi A, Manco M, Panera N, Nobili V. Association between type two diabetes and non-alcoholic fatty liver disease in youth. Annals of Hepatology 2009;8:S44-50. [DOI: 10.1016/s1665-2681(19)31826-5] [Cited by in Crossref: 23] [Article Influence: 1.8] [Reference Citation Analysis]
31 Maurantonio M, Ballestri S, Odoardi MR, Lonardo A, Loria P. Treatment of atherogenic liver based on the pathogenesis of nonalcoholic fatty liver disease: a novel approach to reduce cardiovascular risk? Arch Med Res. 2011;42:337-353. [PMID: 21843565 DOI: 10.1016/j.arcmed.2011.08.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
32 Wang AY, Dhaliwal J, Mouzaki M. Lean non-alcoholic fatty liver disease. Clin Nutr. 2019;38:975-981. [PMID: 30466956 DOI: 10.1016/j.clnu.2018.08.008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
33 Hooper AJ, Adams LA, Burnett JR. Genetic determinants of hepatic steatosis in man. J Lipid Res 2011;52:593-617. [PMID: 21245030 DOI: 10.1194/jlr.R008896] [Cited by in Crossref: 83] [Cited by in F6Publishing: 55] [Article Influence: 7.5] [Reference Citation Analysis]
34 Sun P, Wang Q. Relationship between vitamin D receptor gene polymorphisms and alcoholic liver disease. Shijie Huaren Xiaohua Zazhi 2009; 17(3): 273-278 [DOI: 10.11569/wcjd.v17.i3.273] [Reference Citation Analysis]
35 Adachi M, Ishii H. Hyperadiponectinemia in alcoholic liver disease: Friend or foe? Journal of Gastroenterology and Hepatology 2009;24:507-8. [DOI: 10.1111/j.1440-1746.2009.05807.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
36 Stefan N, Kantartzis K, Häring H. Causes and Metabolic Consequences of Fatty Liver. Endocrine Reviews 2008;29:939-60. [DOI: 10.1210/er.2008-0009] [Cited by in Crossref: 338] [Cited by in F6Publishing: 318] [Article Influence: 24.1] [Reference Citation Analysis]
37 Yang Z, Wen J, Li Q, Tao X, Ye Z, He M, Zhang W, Huang Y, Chen L, Ling C. PPARG gene Pro12Ala variant contributes to the development of non-alcoholic fatty liver in middle-aged and older Chinese population. Mol Cell Endocrinol. 2012;348:255-259. [PMID: 21939732 DOI: 10.1016/j.mce.2011.09.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
38 Puppala J, Siddapuram SP, Akka J, Munshi A. Genetics of nonalcoholic Fatty liver disease: an overview. J Genet Genomics. 2013;40:15-22. [PMID: 23357341 DOI: 10.1016/j.jgg.2012.12.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
39 Sanal MG. The blind men ‘see’ the elephant-the many faces of fatty liver disease. World J Gastroenterol 2008; 14(6): 831-844 [PMID: 18240340 DOI: 10.3748/wjg.14.831] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
40 Yang K, Huang Y, Perng C, Lin H, Lee S. Polymorphism of N-acetyltransferase 2 Gene and the Susceptibility to Alcoholic Liver Cirrhosis: Interaction With Smoking: NAT2 GENE AND ALCOHOLIC LIVER CIRRHOSIS. Alcoholism: Clinical and Experimental Research 2011;35:1204-8. [DOI: 10.1111/j.1530-0277.2011.01453.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
41 Hritz I, Mandrekar P, Velayudham A, Catalano D, Dolganiuc A, Kodys K, Kurt-Jones E, Szabo G. The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology. 2008;48:1224-1231. [PMID: 18792393 DOI: 10.1002/hep.22470] [Cited by in Crossref: 257] [Cited by in F6Publishing: 264] [Article Influence: 18.4] [Reference Citation Analysis]
42 Yeh MM, Brunt EM. Pathological Features of Fatty Liver Disease. Gastroenterology 2014;147:754-64. [DOI: 10.1053/j.gastro.2014.07.056] [Cited by in Crossref: 184] [Cited by in F6Publishing: 162] [Article Influence: 23.0] [Reference Citation Analysis]
43 Bailey SM, Mantena SK, Millender-Swain T, Cakir Y, Jhala NC, Chhieng D, Pinkerton KE, Ballinger SW. Ethanol and tobacco smoke increase hepatic steatosis and hypoxia in the hypercholesterolemic apoE(-/-) mouse: implications for a "multihit" hypothesis of fatty liver disease. Free Radic Biol Med 2009;46:928-38. [PMID: 19280709 DOI: 10.1016/j.freeradbiomed.2009.01.003] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
44 Petrásek J, Hubácek JA, Stickel F, Sperl J, Berg T, Ruf E, Wichmann HE, Pfeufer A, Meitinger T, Trunecka P. Do common genetic variants in endotoxin signaling pathway contribute to predisposition to alcoholic liver cirrhosis? Clin Chem Lab Med. 2009;47:398-404. [PMID: 19278365 DOI: 10.1515/cclm.2009.112] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
45 DiStefano JK, Kingsley C, Craig Wood G, Chu X, Argyropoulos G, Still CD, Doné SC, Legendre C, Tembe W, Gerhard GS. Genome-wide analysis of hepatic lipid content in extreme obesity. Acta Diabetol 2015;52:373-82. [PMID: 25246029 DOI: 10.1007/s00592-014-0654-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
46 Malik R, Chang M, Bhaskar K, Nasser I, Curry M, Schuppan D, Byrnes V, Afdhal N. The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol. 2009;24:564-568. [PMID: 19378390 DOI: 10.1111/j.1440-1746.2008.05731.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 4.7] [Reference Citation Analysis]
47 Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology. 2009;50:1094-1104. [PMID: 19637282 DOI: 10.1002/hep.23122] [Cited by in Crossref: 352] [Cited by in F6Publishing: 351] [Article Influence: 27.1] [Reference Citation Analysis]
48 Brunt EM, Tiniakos DG. Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol 2010; 16(42): 5286-5296 [PMID: 21072891 DOI: 10.3748/wjg.v16.i42.5286] [Cited by in CrossRef: 230] [Cited by in F6Publishing: 210] [Article Influence: 19.2] [Reference Citation Analysis]
49 Reuben A. Alcohol and the liver. Curr Opin Gastroenterol. 2007;23:283-291. [PMID: 17414844 DOI: 10.1097/mog.0b013e3280f27582] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
50 Sid B, Verrax J, Calderon PB. Role of oxidative stress in the pathogenesis of alcohol-induced liver disease. Free Radic Res. 2013;47:894-904. [PMID: 23800214 DOI: 10.3109/10715762.2013.819428] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 6.1] [Reference Citation Analysis]
51 Gonzalez-Quintela A, Campos J, Loidi L, Quinteiro C, Perez LF, Gude F. Serum TNF-alpha levels in relation to alcohol consumption and common TNF gene polymorphisms. Alcohol. 2008;42:513-518. [PMID: 18579335 DOI: 10.1016/j.alcohol.2008.04.008] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
52 Yoon YH, Yi HY, Thomson PC. Alcohol-related and viral hepatitis C-related cirrhosis mortality among Hispanic subgroups in the United States, 2000-2004. Alcohol Clin Exp Res 2011;35:240-9. [PMID: 21121934 DOI: 10.1111/j.1530-0277.2010.01340.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
53 Dehghani Amirabad A, Ramasamy P, Wierz M, Nordström K, Kessler SM, Schulz MH, Simon M. Transgenic expression of the RNA binding protein IMP2 stabilizes miRNA targets in murine microsteatosis. Biochim Biophys Acta Mol Basis Dis 2018;1864:3099-108. [PMID: 29859241 DOI: 10.1016/j.bbadis.2018.05.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
54 Gerhard GS, Davis B, Wu X, Hanson A, Wilhelmsen D, Piras IS, Still CD, Chu X, Petrick AT, DiStefano JK. Differentially expressed mRNAs and lncRNAs shared between activated human hepatic stellate cells and nash fibrosis. Biochem Biophys Rep 2020;22:100753. [PMID: 32258441 DOI: 10.1016/j.bbrep.2020.100753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
55 Mantena SK, King AL, Andringa KK, Landar A, Darley-Usmar V, Bailey SM. Novel interactions of mitochondria and reactive oxygen/nitrogen species in alcohol mediated liver disease. World J Gastroenterol 2007; 13(37): 4967-4973 [PMID: 17854139 DOI: 10.3748/wjg.v13.i37.4967] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
56 Auguet T, Vidal F, Broch M, Olona M, Aguilar C, Morancho B, López-Dupla M, Quer JC, Sirvent JJ, Richart C. Polymorphisms in the interleukin-10 gene promoter and the risk of alcoholism and alcoholic liver disease in Caucasian Spaniard men. Alcohol 2010;44:211-6. [PMID: 20570082 DOI: 10.1016/j.alcohol.2010.02.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
57 Wang B, Hsu SH, Majumder S, Kutay H, Huang W, Jacob ST, Ghoshal K. TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene. 2010;29:1787-1797. [PMID: 20023698 DOI: 10.1038/onc.2009.468] [Cited by in Crossref: 254] [Cited by in F6Publishing: 261] [Article Influence: 19.5] [Reference Citation Analysis]
58 Wieckowska A, McCullough AJ, Feldstein AE. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology. 2007;46:582-589. [PMID: 17661414 DOI: 10.1002/hep.21768] [Cited by in Crossref: 294] [Cited by in F6Publishing: 282] [Article Influence: 19.6] [Reference Citation Analysis]
59 Matsushita N, Osaka T, Haruta I, Ueshiba H, Yanagisawa N, Omori-Miyake M, Hashimoto E, Shibata N, Tokushige K, Saito K. Effect of Lipopolysaccharide on the Progression of Non-Alcoholic Fatty Liver Disease in High Caloric Diet-Fed Mice. Scand J Immunol. 2016;83:109-118. [PMID: 26524607 DOI: 10.1111/sji.12397] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
60 Banerjee Y, Santos RD, Al-Rasadi K, Rizzo M. Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns? Atherosclerosis 2016;248:62-75. [PMID: 26987067 DOI: 10.1016/j.atherosclerosis.2016.02.018] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
61 Partridge CG, Fawcett GL, Wang B, Semenkovich CF, Cheverud JM. The effect of dietary fat intake on hepatic gene expression in LG/J AND SM/J mice. BMC Genomics 2014;15:99. [PMID: 24499025 DOI: 10.1186/1471-2164-15-99] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
62 Virmani A, Ali SF, Binienda ZK. Neuroprotective strategies in drug abuse-evoked encephalopathy. Ann N Y Acad Sci 2010;1199:52-68. [PMID: 20633109 DOI: 10.1111/j.1749-6632.2009.05171.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
63 Albano E. Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Mol Aspects Med. 2008;29:9-16. [PMID: 18045675 DOI: 10.1016/j.mam.2007.09.004] [Cited by in Crossref: 194] [Cited by in F6Publishing: 182] [Article Influence: 12.9] [Reference Citation Analysis]
64 Feldstein AE, Bailey SM. Emerging role of redox dysregulation in alcoholic and nonalcoholic fatty liver disease. Antioxid Redox Signal. 2011;15:421-424. [PMID: 21254858 DOI: 10.1089/ars.2011.3897] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
65 Loomba R, Rao F, Zhang L, Khandrika S, Ziegler MG, Brenner DA, O’Connor DT. Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins. Gastroenterology. 2010;139:836-845, 845.e1. [PMID: 20537997 DOI: 10.1053/j.gastro.2010.06.009] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
66 Mitchell T, Chacko B, Ballinger SW, Bailey SM, Zhang J, Darley-Usmar V. Convergent mechanisms for dysregulation of mitochondrial quality control in metabolic disease: implications for mitochondrial therapeutics. Biochem Soc Trans 2013;41:127-33. [PMID: 23356271 DOI: 10.1042/BST20120231] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
67 Fawcett GL, Roseman CC, Jarvis JP, Wang B, Wolf JB, Cheverud JM. Genetic architecture of adiposity and organ weight using combined generation QTL analysis. Obesity (Silver Spring) 2008;16:1861-8. [PMID: 18551125 DOI: 10.1038/oby.2008.300] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
68 Burra P, De Martin E, Gitto S, Villa E. Influence of age and gender before and after liver transplantation. Liver Transpl. 2013;19:122-134. [PMID: 23172830 DOI: 10.1002/lt.23574] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
69 Mencarelli A, Cipriani S, Renga B, Bruno A, D'Amore C, Distrutti E, Fiorucci S. VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation. PLoS One. 2012;7:e45425. [PMID: 23029000 DOI: 10.1371/journal.pone.0045425] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 6.2] [Reference Citation Analysis]
70 Bujanda L, Hijona E, Larzabal M, Beraza M, Aldazabal P, García-Urkia N, Sarasqueta C, Cosme A, Irastorza B, González A. Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterol. 2008;8:40. [PMID: 18782455 DOI: 10.1186/-1471-230x-8-40] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Xia Y, Wu Q, Dai H, Lv J, Liu Y, Sun H, Jiang Y, Chang Q, Niu K, Zhao Y. Associations of Nutritional, Lifestyle, and Metabolic Factors With Non-alcoholic Fatty Liver Disease: An Umbrella Review With More Than 380,000 Participants. Front Nutr 2021;8:642509. [PMID: 34604270 DOI: 10.3389/fnut.2021.642509] [Reference Citation Analysis]
72 Tonan T, Fujimoto K, Qayyum A, Morita Y, Nakashima O, Ono N, Kawahara A, Kage M, Hayabuchi N, Ueno T. CD14 expression and Kupffer cell dysfunction in non-alcoholic steatohepatitis: superparamagnetic iron oxide-magnetic resonance image and pathologic correlation. J Gastroenterol Hepatol. 2012;27:789-796. [PMID: 22188204 DOI: 10.1111/j.1440-1746.2011.07057.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
73 Camps J, Marsillach J, Rull A, Alonso-Villaverde C, Joven J. Interrelationships between paraoxonase-1 and monocyte chemoattractant protein-1 in the regulation of hepatic inflammation. Adv Exp Med Biol. 2010;660:5-18. [PMID: 20221866 DOI: 10.1007/978-1-60761-350-3_2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
74 Yoon YH, Chen CM, Slater ME, Jung MK, White AM. Trends in Premature Deaths From Alcoholic Liver Disease in the U.S., 1999-2018. Am J Prev Med 2020;59:469-80. [PMID: 32863077 DOI: 10.1016/j.amepre.2020.04.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 M. Brunt E, G. Tiniakos D. Fatty Liver Disease. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Elsevier; 2009. pp. 1087-114. [DOI: 10.1016/b978-141604059-0.50044-8] [Cited by in Crossref: 8] [Article Influence: 0.6] [Reference Citation Analysis]
76 Abenavoli L, Milic N, De Lorenzo A, Luzza F. A pathogenetic link between non-alcoholic fatty liver disease and celiac disease. Endocrine. 2013;43:65-67. [PMID: 22740094 DOI: 10.1007/s12020-012-9731-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
77 Hübscher SG. Alcohol-Induced Liver Disease. Practical Hepatic Pathology: A Diagnostic Approach. Elsevier; 2011. pp. 417-33. [DOI: 10.1016/b978-0-443-06803-4.00030-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
78 Tian Y, Fan ZP, Qiu DK, Ding J, Liu JP, Gao YM. Cholesterol metabolism in cultured steatotic hepatocytes. Shijie Huaren Xiaohua Zazhi 2008; 16(10): 1031-1036 [DOI: 10.11569/wcjd.v16.i10.1031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Jourdan T, Nicoloro SM, Zhou Z, Shen Y, Liu J, Coffey NJ, Cinar R, Godlewski G, Gao B, Aouadi M, Czech MP, Kunos G. Decreasing CB1 receptor signaling in Kupffer cells improves insulin sensitivity in obese mice. Mol Metab 2017;6:1517-28. [PMID: 29107297 DOI: 10.1016/j.molmet.2017.08.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
80 Woo GA, O'Brien C. Long-term management of alcoholic liver disease. Clin Liver Dis 2012;16:763-81. [PMID: 23101981 DOI: 10.1016/j.cld.2012.08.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
81 Yang YY, Lin HC. Cross-regulation of cannabinoid CB₁ and CB₂ receptors governs hepatic steatosis. Liver Int 2010;30:1397-9. [PMID: 20860563 DOI: 10.1111/j.1478-3231.2010.02352.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
82 Jia Q, Xia Y, Zhang Q, Wu H, Du H, Liu L, Wang C, Shi H, Guo X, Liu X, Li C, Sun S, Wang X, Zhao H, Song K, Huang G, Wu Y, Cui N, Niu K. Dietary patterns are associated with prevalence of fatty liver disease in adults. Eur J Clin Nutr 2015;69:914-21. [PMID: 25649235 DOI: 10.1038/ejcn.2014.297] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 7.6] [Reference Citation Analysis]
83 Virmani A, Binienda ZK, Ali SF, Gaetani F. Metabolic Syndrome in Drug Abuse. Annals of the New York Academy of Sciences 2007;1122:50-68. [DOI: 10.1196/annals.1403.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
84 Liu T, Yu XH, Gao EZ, Liu XN, Sun LJ, Li HL, Wang P, Zhao YL, Yu ZG. Hepatoprotective Effect of Active Constituents Isolated from Mung Beans ( Phaseolus radiatus L.) in an Alcohol-Induced Liver Injury Mouse Model: Hepatoprotective Effect of Mung Beans. Journal of Food Biochemistry 2014;38:453-9. [DOI: 10.1111/jfbc.12083] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
85 Gouda W, Ashour E, Shaker Y, Ezzat W. MTP genetic variants associated with non-alcoholic fatty liver in metabolic syndrome patients. Genes Dis 2017;4:222-8. [PMID: 30258926 DOI: 10.1016/j.gendis.2017.09.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
86 Sid B, Verrax J, Calderon PB. Role of AMPK activation in oxidative cell damage: Implications for alcohol-induced liver disease. Biochem Pharmacol. 2013;86:200-209. [PMID: 23688501 DOI: 10.1016/j.bcp.2013.05.007] [Cited by in Crossref: 94] [Cited by in F6Publishing: 91] [Article Influence: 10.4] [Reference Citation Analysis]
87 Poulsen MM, Larsen JØ, Hamilton-Dutoit S, Clasen BF, Jessen N, Paulsen SK, Kjær TN, Richelsen B, Pedersen SB. Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet. Nutr Res 2012;32:701-8. [PMID: 23084643 DOI: 10.1016/j.nutres.2012.08.004] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 6.3] [Reference Citation Analysis]
88 Sookoian S, Castaño G, Gemma C, Gianotti TF, Pirola CJ. Common genetic variations in CLOCK transcription factor are associated with nonalcoholic fatty liver disease. World J Gastroenterol 2007; 13(31): 4242-4248 [PMID: 17696255 DOI: 10.3748/wjg.v13.i31.4242] [Cited by in CrossRef: 79] [Cited by in F6Publishing: 73] [Article Influence: 5.3] [Reference Citation Analysis]
89 Mancina RM, Ferri F, Farcomeni A, Molinaro A, Maffongelli A, Mischitelli M, Poli E, Parlati L, Burza MA, De Santis A, Attilia F, Rotondo C, Rando MM, Attilia ML, Ceccanti M, Ginanni Corradini S. A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption. Appl Clin Genet 2019;12:1-10. [PMID: 30666147 DOI: 10.2147/TACG.S187922] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
90 Nagarajan P, Venkatesan R, Kumar M, Usmani A, Majumdar SS. Macaca radiata (bonnet monkey): a spontaneous model of nonalcoholic fatty liver disease. Liver Int 2008;28:856-64. [PMID: 18346131 DOI: 10.1111/j.1478-3231.2008.01706.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
91 Dumortier J, Giostra E, Belbouab S, Morard I, Guillaud O, Spahr L, Boillot O, Rubbia-Brandt L, Scoazec JY, Hadengue A. Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil". Am J Gastroenterol. 2010;105:613-620. [PMID: 20040915 DOI: 10.1038/ajg.2009.717] [Cited by in Crossref: 140] [Cited by in F6Publishing: 119] [Article Influence: 10.8] [Reference Citation Analysis]
92 Oh MK, Winn J, Poordad F. Review article: diagnosis and treatment of non-alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 2008;28:503-22. [DOI: 10.1111/j.1365-2036.2008.03752.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 70] [Article Influence: 4.9] [Reference Citation Analysis]
93 Kapil S, Duseja A, Sharma BK, Singla B, Chakraborti A, Das A, Ray P, Dhiman RK, Chawla Y. Genetic polymorphism in CD14 gene, a co-receptor of TLR4 associated with non-alcoholic fatty liver disease. World J Gastroenterol 2016; 22(42): 9346-9355 [PMID: 27895422 DOI: 10.3748/wjg.v22.i42.9346] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
94 Bujanda L, Hijona E, Larzabal M, Beraza M, Aldazabal P, García-Urkia N, Sarasqueta C, Cosme A, Irastorza B, González A. Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterol. 2008;8:40. [PMID: 18782455 DOI: 10.1186/1471-230x-8-40] [Cited by in Crossref: 130] [Cited by in F6Publishing: 59] [Article Influence: 9.3] [Reference Citation Analysis]
95 Hanson A, Wilhelmsen D, DiStefano JK. The Role of Long Non-Coding RNAs (lncRNAs) in the Development and Progression of Fibrosis Associated with Nonalcoholic Fatty Liver Disease (NAFLD). Noncoding RNA 2018;4:E18. [PMID: 30134610 DOI: 10.3390/ncrna4030018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
96 Khan RS, Newsome PN. Non-alcoholic fatty liver disease and liver transplantation. Metabolism. 2016;65:1208-1223. [PMID: 26997540 DOI: 10.1016/j.metabol.2016.02.013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
97 Hattar LN, Wilson TA, Tabotabo LA, Smith EO, Abrams SH. Physical activity and nutrition attitudes in obese Hispanic children with non-alcoholic steatohepatitis. World J Gastroenterol 2011; 17(39): 4396-4403 [PMID: 22110265 DOI: 10.3748/wjg.v17.i39.4396] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
98 Xu T, Zheng L, Xu L, Yin L, Qi Y, Xu Y, Han X, Peng J. Protective effects of dioscin against alcohol-induced liver injury. Arch Toxicol 2014;88:739-53. [PMID: 24146112 DOI: 10.1007/s00204-013-1148-8] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
99 Ellefson WM, Lakner AM, Hamilton A, McKillop IH, Bonkovsky HL, Steuerwald NM, Huet YM, Schrum LW. Neonatal androgenization exacerbates alcohol-induced liver injury in adult rats, an effect abrogated by estrogen. PLoS One 2011;6:e29463. [PMID: 22206017 DOI: 10.1371/journal.pone.0029463] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
100 Mehta R, Birerdinc A, Younossi ZM. Host genetic variants in obesity-related nonalcoholic fatty liver disease. Clin Liver Dis 2014;18:249-67. [PMID: 24274878 DOI: 10.1016/j.cld.2013.09.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
101 Mas VR, Fisher RA, Archer KJ, Maluf DG. Proteomics and liver fibrosis: identifying markers of fibrogenesis. Expert Rev Proteomics. 2009;6:421-431. [PMID: 19681677 DOI: 10.1586/epr.09.59] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
102 Hellerbrand C. Pathophysiological similarities and synergisms in alcoholic and non-alcoholic steatohepatitis. Dig Dis. 2010;28:783-791. [PMID: 21525763 DOI: 10.1159/000324286] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
103 Tomita K, Oike Y, Teratani T, Taguchi T, Noguchi M, Suzuki T, Mizutani A, Yokoyama H, Irie R, Sumimoto H. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice. Hepatology. 2008;48:458-473. [PMID: 18666257 DOI: 10.1002/hep.22365] [Cited by in Crossref: 88] [Cited by in F6Publishing: 93] [Article Influence: 6.3] [Reference Citation Analysis]
104 Said A. Non-alcoholic fatty liver disease and liver transplantation: Outcomes and advances. World J Gastroenterol 2013; 19(48): 9146-9155 [PMID: 24409043 DOI: 10.3748/wjg.v19.i48.9146] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
105 Hernaez R, Yeung E, Clark JM, Kowdley KV, Brancati FL, Kao WH. Hemochromatosis gene and nonalcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol. 2011;55:1079-1085. [PMID: 21354231 DOI: 10.1016/j.jhep.2011.02.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
106 Kamagate A, Dong HH. FoxO1 integrates insulin signaling to VLDL production. Cell Cycle 2008;7:3162-70. [PMID: 18927507 DOI: 10.4161/cc.7.20.6882] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 5.3] [Reference Citation Analysis]
107 Gonzalez-Quintela A, Tomé S, Fernandez-Merino C, Rey J, Meijide L, Gude F. Synergistic effect of alcohol consumption and body mass on serum concentrations of cytokeratin-18. Alcohol Clin Exp Res. 2011;35:2202-2208. [PMID: 21682752 DOI: 10.1111/j.1530-0277.2011.01570.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
108 Kamagate A, Qu S, Perdomo G, Su D, Kim DH, Slusher S, Meseck M, Dong HH. FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. J Clin Invest. 2008;118:2347-2364. [PMID: 18497885 DOI: 10.1172/jci32914] [Cited by in Crossref: 18] [Cited by in F6Publishing: 115] [Article Influence: 1.3] [Reference Citation Analysis]
109 Cao CY, Li YY, Zhou YJ, Nie YQ, Wan YJ. The C-681G polymorphism of the PPAR-γ gene is associated with susceptibility to non-alcoholic fatty liver disease. Tohoku J Exp Med 2012;227:253-62. [PMID: 22820754 DOI: 10.1620/tjem.227.253] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
110 Camps J, Marsillach J, Joven J. Measurement of serum paraoxonase-1 activity in the evaluation of liver function. World J Gastroenterol 2009; 15(16): 1929-1933 [PMID: 19399923 DOI: 10.3748/wjg.15.1929] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
111 Machado MV, Ravasco P, Martins A, Almeida MR, Camilo ME, Cortez-Pinto H. Iron homeostasis and H63D mutations in alcoholics with and without liver disease. World J Gastroenterol 2009; 15(1): 106-111 [PMID: 19115475 DOI: 10.3748/wjg.15.106] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
112 Ebrahimzadeh Leylabadlo H, Ghotaslou R, Samadi Kafil H, Feizabadi MM, Moaddab SY, Farajnia S, Sheykhsaran E, Sanaie S, Shanehbandi D, Bannazadeh Baghi H. Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies. Eur J Clin Microbiol Infect Dis 2020;39:613-27. [PMID: 31828683 DOI: 10.1007/s10096-019-03746-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
113 Wang J, Li P, Jiang Z, Yang Q, Mi Y, Liu Y, Shi R, Zhou Y, Wang J, Lu W, Li S, Liu D. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD. Korean J Intern Med 2016;31:479-87. [PMID: 27025268 DOI: 10.3904/kjim.2015.253] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
114 Zhou YJ, Li YY, Nie YQ, Yang H, Zhan Q, Huang J, Shi SL, Lai XB, Huang HL. Influence of polygenetic polymorphisms on the susceptibility to non-alcoholic fatty liver disease of Chinese people. J Gastroenterol Hepatol. 2010;25:772-777. [PMID: 20492333 DOI: 10.1111/j.1440-1746.2009.06144.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 4.0] [Reference Citation Analysis]